FdaApplication
ANDA 079028
Identifiers
- fda_app_no: ANDA079028
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC |
| application_type | ANDA |
| approval_date | 2008-12-15 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GALANTAMINE HYDROBROMIDE | GALANTAMINE HYDROBROMIDE | EQ 16MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| GALANTAMINE HYDROBROMIDE | GALANTAMINE HYDROBROMIDE | EQ 24MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| GALANTAMINE HYDROBROMIDE | GALANTAMINE HYDROBROMIDE | EQ 8MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
3 products